These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6330664

  • 21. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
    Juszczak M, Boczek-Leszczyk E, Stempniak B.
    J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
    [Abstract] [Full Text] [Related]

  • 22. Arginine vasopressin enhances periaqueductal gray synthesis and secretion of enkephalin and endorphin in the rat.
    Yang J, Yang Y, Xu HT, Chen JM, Liu WY, Lin BC.
    Brain Res Bull; 2006 Dec 11; 71(1-3):193-9. PubMed ID: 17113946
    [Abstract] [Full Text] [Related]

  • 23. Only arginine vasopressin, not oxytocin and endogenous opiate peptides, in hypothalamic paraventricular nucleus play a role in acupuncture analgesia in the rat.
    Yang J, Liu WY, Song CY, Lin BC.
    Brain Res Bull; 2006 Feb 15; 68(6):453-8. PubMed ID: 16459202
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
    Qadri F, Culman J, Veltmar A, Maas K, Rascher W, Unger T.
    J Pharmacol Exp Ther; 1993 Nov 15; 267(2):567-74. PubMed ID: 8246129
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
    Hartman RD, Rosella-Dampman LM, Emmert SE, Summy-Long JY.
    Brain Res; 1986 Sep 24; 382(2):352-9. PubMed ID: 3756522
    [Abstract] [Full Text] [Related]

  • 26. Bifemelane hydrochloride reduces plasma beta-endorphin-like immunoreactivity levels in rats.
    Mitsuma T, Hirooka Y, Yuasa K, Nogimori T.
    Exp Clin Endocrinol; 1990 Aug 24; 95(3):301-5. PubMed ID: 2245819
    [Abstract] [Full Text] [Related]

  • 27. Sensitivity of hypothalamic paraventricular nucleus to C- and N-terminal angiotensin fragments: vasopressin release and drinking.
    Qadri F, Wolf A, Waldmann T, Rascher W, Unger T.
    J Neuroendocrinol; 1998 Apr 24; 10(4):275-81. PubMed ID: 9630397
    [Abstract] [Full Text] [Related]

  • 28. Mechanism of the post-haemorrhagic vasopressin release from the posterior pituitary lobe.
    Lipińska S, Traczyk WZ, Kokot F.
    Acta Physiol Pol; 1986 Apr 24; 37(3):109-17. PubMed ID: 3548218
    [Abstract] [Full Text] [Related]

  • 29. Ca2+ clearance mechanisms in neurohypophysial terminals of the rat.
    Sasaki N, Dayanithi G, Shibuya I.
    Cell Calcium; 2005 Jan 24; 37(1):45-56. PubMed ID: 15541463
    [Abstract] [Full Text] [Related]

  • 30. Arginine8 vasopressin potentiates the beta-endorphin-releasing activity of ovine corticotropin-releasing factor (oCRF) in vitro.
    Culler MD, Turkelson CM, Thomas CR, Arimura A.
    Proc Soc Exp Biol Med; 1983 Jun 24; 173(2):264-9. PubMed ID: 6306671
    [Abstract] [Full Text] [Related]

  • 31. Subchronic treatment with fragments of beta-endorphin prevents electroencephalographic seizures and behavioral alterations induced by centrally administered beta-endorphin in the rabbit.
    Di Giannuario A, Pieretti S, Luzi M, Loizzo A.
    J Pharmacol Exp Ther; 1994 Feb 24; 268(2):1040-50. PubMed ID: 8113960
    [Abstract] [Full Text] [Related]

  • 32. Non-opiate beta-endorphin fragments and dopamine--II. beta-Endorphin 2-9 enhances apomorphine-induced stereotypy following subcutaneous and intra-striatal injection.
    Van Ree JM.
    Neuropharmacology; 1982 Nov 24; 21(11):1103-9. PubMed ID: 6891031
    [Abstract] [Full Text] [Related]

  • 33. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
    Ciosek J.
    J Physiol Pharmacol; 2002 Sep 24; 53(3):423-37. PubMed ID: 12369739
    [Abstract] [Full Text] [Related]

  • 34. Behavioral effects of non-opioid fragments of beta-endorphin.
    van Ree JM, de Wied D.
    Prog Clin Biol Res; 1985 Sep 24; 192():277-84. PubMed ID: 2934744
    [Abstract] [Full Text] [Related]

  • 35. Effect of tamoxifen on pituitary vasopressin level.
    Kundi SA, Forsling M, Kleimestur H, Wazir S, Khan TM.
    J Ayub Med Coll Abbottabad; 2004 Sep 24; 16(4):80-3. PubMed ID: 15762072
    [Abstract] [Full Text] [Related]

  • 36. Chronic osmotic stimuli increase salusin-beta-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-beta on [Ca2+]i increase and neurohypophyseal hormone release from the axon terminals.
    Saito T, Dayanithi G, Saito J, Onaka T, Urabe T, Watanabe TX, Hashimoto H, Yokoyama T, Fujihara H, Yokota A, Nishizawa S, Hirata Y, Ueta Y.
    J Neuroendocrinol; 2008 Feb 24; 20(2):207-19. PubMed ID: 18047553
    [Abstract] [Full Text] [Related]

  • 37. Neurohypophysial peptides. Histaminergic regulation and function in adenohypophysial secretion.
    Kjaer A.
    Dan Med Bull; 1996 Dec 24; 43(5):391-406. PubMed ID: 8960813
    [Abstract] [Full Text] [Related]

  • 38. Effects of eel calcitonin on plasma beta-endorphin-like immunoreactivity levels in rats.
    Mitsuma T, Hirooka Y, Nomura A, Okamoto H, Nogimori T.
    Endocrinol Exp; 1988 Jun 24; 22(2):107-12. PubMed ID: 2970383
    [Abstract] [Full Text] [Related]

  • 39. Des-tyr-gamma-endorphin (DT gamma E) and pineal levels of melatonin and arginine vasopressin (AVP).
    King MG, Geffard MR, Chavreau J, Gaffori O, Le Moal M, Muyard JP.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):271-4. PubMed ID: 6120844
    [Abstract] [Full Text] [Related]

  • 40. In vitro release of hypothalamic beta-endorphin (beta E) by arginine vasopressin, corticotropin-releasing hormone and 5-hydroxytryptamine: evidence for release of opioid active and inactive beta E forms.
    Bronstein DM, Akil H.
    Neuropeptides; 1990 May 03; 16(1):33-40. PubMed ID: 2250765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.